Application of molecular dynamics-based pharmacophore and machine learning approaches to identify novel Mcl1 inhibitors through drug repurposing and mechanics research

Abstract

This work introduced an innovative drug repurposing solution involving MD-refined pharmacophore and machine learning methods. Fluvastatin was successfully identified as a potential Mcl1 inhibitor through flow cytometry and other in silico methods.